A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
第一作者:
D,Pectasides
第一单位:
Second Department of Internal Medicine, Propaedeutic, Oncology Section, Attikon University Hospital, Athens, Greece. pectasid@otenet.gr
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);止吐药(Antiemetics);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);表柔比星(Epirubicin);女(雌)性(Female);人类(Humans);中年人(Middle Aged);昂丹司琼(Ondansetron);片剂(Tablets);呕吐(Vomiting)
PMID
18214053
发布时间
2013-11-21
- 浏览6
Anticancer research
4411-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文